DRUG NEWS: New drugs in the marketplace

$3.95
Nursing2014
July 2004 
Volume 34  Number 7
Pages 26 - 26
 
  PDF Version Available!

ABSTRACT
© 2004 Lippincott Williams & Wilkins, Inc. Volume 34(7)             July 2004             p 26 New drugs in the marketplace [DRUG NEWS]

These drugs were recently approved by the FDA:

* apomorphine HCl (Apokyn) for patients with Parkinson's disease who develop hypomobility. After 3 to 5 years of treatment with standard Parkinson's drugs, about 10% of patients experience episodes of being unable to speak or walk, known as hypomobility. Apokyn, which is injected, can cause severe nausea and must be taken with an antiemetic.

* fluticasone propionate and salmeterol 100/50 mcg inhalation powder (Advair Diskus) for childhood asthma. Available since 2001 for people ages 12 and older, Advair is now approved for use in children ages 4 to 11 years old with asthma that's symptomatic despite corticosteroid therapy. Because Advair contains both an inhaled corticosteroid and a long-acting ...

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!


Cost:$3.95
1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Password


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.


Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.






Featured Jobs



Benefits of Membership

FREE E-Newsletters
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues

CESaver
Join our CESaver program to earn up to 100 contact hours for only $34.95
Register Now

Lippincott's NursingCenter.com
Explore a world of online resources

Become a Member